Cell populations comprising CD31-positive, CD45-negative, CD200-positive mammalian cells, and use thereof

• 收藏
• 分享

专利权人:

Osaka University

发明人:

TAKAKURA, Nobuyuki,NAITO, Hisamichi,WAKABAYASHI, Taku

申请号：

AU2018367552

公开号：

AU2018367552A1

申请日:

2018.11.15

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

Provided are: a cell population which is essentially formed from mammalian cells in which cell surface markers CD31 and CD200 are positive, and cell surface marker CD45 is negative； a cell population which is essentially formed from mammalian cells in which cell surface markers CD31, CD157, and CD200 are positive, and cell surface marker CD45 is negative； mammalian vascular endothelial stem cells in which cell surface marker CD31 is positive, cell surface marker CD157 and/or cell surface marker CD200 are/is positive, and cell surface marker CD45 is negative； and a revascularizing pharmaceutical having, as an active ingredient, the cell populations or the vascular endothelial stem cells.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/